AstraZeneca (GB:AZN) has released an update.
AstraZeneca PLC has announced that as of July 31, 2024, their issued share capital with voting rights stands at 1,550,277,001 ordinary shares, none of which are held in Treasury. This figure is relevant for shareholders who need to determine if they must disclose changes in their stake in the company, per the UK Financial Conduct Authority’s Disclosure and Transparency Rules. AstraZeneca is a global biopharmaceutical company, headquartered in Cambridge, UK, focusing on prescription medicines across a range of areas including Oncology and Cardiovascular diseases, with a presence in over 125 countries.
For further insights into GB:AZN stock, check out TipRanks’ Stock Analysis page.
